Similar articles for PMID: 12510950

Year	Number of Results
1998	1
2001	1
2002	1
2003	5
2004	9
2005	9
2006	7
2007	6
2008	5
2009	1
2010	1
2011	1
2012	3
2013	2
2024	0

1

High density lipoprotein: guardian of the vascular system?

Packard C, Nunn A, Hobbs R; Future Forum Editorial Board. Packard C, et al. Int J Clin Pract. 2002 Dec;56(10):761-71. Int J Clin Pract. 2002. PMID: 12510950 Review.

2

Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.

Chapman MJ, Assmann G, Fruchart JC, Shepherd J, Sirtori C; European Consensus Panel on HDL-C. Chapman MJ, et al. Curr Med Res Opin. 2004 Aug;20(8):1253-68. doi: 10.1185/030079904125004402. Curr Med Res Opin. 2004. PMID: 15324528 Review.

3

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM. Hausenloy DJ, et al. Heart. 2008 Jun;94(6):706-14. doi: 10.1136/hrt.2007.125401. Heart. 2008. PMID: 18480348 Review.

4

HDL-C: role as a risk modifier.

Barter P. Barter P. Atheroscler Suppl. 2011 Nov;12(3):267-70. doi: 10.1016/S1567-5688(11)70885-6. Atheroscler Suppl. 2011. PMID: 22152280 Review.

5

Have we forgotten the pivotal role of high-density lipoprotein cholesterol in atherosclerosis prevention?

Wierzbicki AS. Wierzbicki AS. Curr Med Res Opin. 2005 Feb;21(2):299-306. doi: 10.1185/030079905X26216. Curr Med Res Opin. 2005. PMID: 15802001 Review.

6

The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.

Temelkova-Kurktschiev T, Hanefeld M. Temelkova-Kurktschiev T, et al. Exp Clin Endocrinol Diabetes. 2004 Feb;112(2):75-9. doi: 10.1055/s-2004-815753. Exp Clin Endocrinol Diabetes. 2004. PMID: 15031770 Review.

7

HDL-c is a powerful lipid predictor of cardiovascular diseases.

Bruckert E, Hansel B. Bruckert E, et al. Int J Clin Pract. 2007 Nov;61(11):1905-13. doi: 10.1111/j.1742-1241.2007.01509.x. Epub 2007 Jul 26. Int J Clin Pract. 2007. PMID: 17655681 Review.

8

Pharmacologic management of isolated low high-density lipoprotein syndrome.

Bermúdez V, Cano R, Cano C, Bermúdez F, Arraiz N, Acosta L, Finol F, Pabón MR, Amell A, Reyna N, Hidalgo J, Kendall P, Manuel V, Hernández R. Bermúdez V, et al. Am J Ther. 2008 Jul-Aug;15(4):377-88. doi: 10.1097/MJT.0b013e318169bc0b. Am J Ther. 2008. PMID: 18645343 Review.

9

Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease.

Chapman MJ. Chapman MJ. Pharmacol Ther. 2006 Sep;111(3):893-908. doi: 10.1016/j.pharmthera.2006.02.003. Epub 2006 Mar 29. Pharmacol Ther. 2006. PMID: 16574234 Review.

10

Low HDL-C: a secondary target of dyslipidemia therapy.

Rosenson RS. Rosenson RS. Am J Med. 2005 Oct;118(10):1067-77. doi: 10.1016/j.amjmed.2004.12.021. Am J Med. 2005. PMID: 16194634 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

51 results

Results by year